Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer. - Svalheim KG; Andresen NK; Bjerre C; Gilje B; Jakobsen EH; Falk RS; Naume B; Kaasa S; Kyte JA (Breast (Edinburgh, Scotland), 2026)